NAGE

Niagen Bioscience Inc$4.84-0.12 (-2.32%)

Prev Close$4.96·MCap$394.8M·P/E24.25·Vol454.5K·Yield—

▲

Buys (12M)

$45.6K

▼

Sells (12M)

$0.00

◆

Net Activity

Net Buyer

$45.6K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Niagen Bioscience Inc (NAGE) has been exclusively buying, with 1 insider purchase totaling $45.6K and 0 insider sales totaling $0.00. The most recent insider transaction was by Pamir Ozan (Chief Financial Officer), who purchased $45.6K worth of shares on Nov 17, 2025. Niagen Bioscience Inc operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $394.8M.

NAGE Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Nov 17, 2025	Pamir Ozan	Chief Financial Officer	Buy	6,684	$6.82	$45.6K	7,372+971%
Mar 10, 2025	Lopez Carlos Luis	SVP, General Counsel	Buy	273	$7.86	$2.1K	2,251
Dec 13, 2024	Jaksch Frank L Jr	Director	Sell	37,161	$6.19	$230.0K	244,179
Nov 25, 2024	Pamir Ozan	Chief Financial Officer	Buy	2,907	$7.36	$21.4K	2,907New Position
Aug 26, 2024	Patrick Kristin	Director	Sell	23,000	$3.57	$82.1K	0Exit
Dec 4, 2023	Gerber Brianna	Chief Financial Officer	Buy	5,000	$1.41	$7.0K	27,436
Jun 13, 2023	Jaksch Frank L Jr	Director	Buy	7,000	$1.69	$11.8K	231,339
Jun 1, 2023	Fried Robert N	Chief Executive Officer	Buy	7,000	$1.42	$9.9K	95,001
May 30, 2023	Rubin Steven D	Director	Buy	7,000	$1.46	$10.2K	7,000
Oct 3, 2022	Chau Hoi Shuen Solina Holly	10% Owner	Buy	960,000	$1.25	$1.20M1.2% OS	7,885,641
Oct 3, 2022	Fried Robert N	Cheif Executive Officer	Buy	80,000	$1.25	$100.0K	972,314
Jun 21, 2022	Chau Hoi Shuen Solina Holly	10% Owner	Buy	60,037	$1.66	$99.9K	6,925,641
Mar 16, 2022	Fried Robert N	CEO	Buy	25,000	$2.16	$54.0K	88,001+40%
May 17, 2021	Fried Robert N	CEO	Buy	10,000	$6.65	$66.5K	63,001
Mar 17, 2021	BLOCK STEPHEN A		Sell	52,500	$11.92	$625.8K	16,667-76%

NAGE Insider Buying Activity

The following table shows recent insider purchases of Niagen Bioscience Inc (NAGE) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Nov 17, 2025	Pamir Ozan	Chief Financial Officer	Buy	6,684	$6.82	$45.6K	7,372+971%
Mar 10, 2025	Lopez Carlos Luis	SVP, General Counsel	Buy	273	$7.86	$2.1K	2,251
Nov 25, 2024	Pamir Ozan	Chief Financial Officer	Buy	2,907	$7.36	$21.4K	2,907New Position
Dec 4, 2023	Gerber Brianna	Chief Financial Officer	Buy	5,000	$1.41	$7.0K	27,436
Jun 13, 2023	Jaksch Frank L Jr	Director	Buy	7,000	$1.69	$11.8K	231,339
Jun 1, 2023	Fried Robert N	Chief Executive Officer	Buy	7,000	$1.42	$9.9K	95,001
May 30, 2023	Rubin Steven D	Director	Buy	7,000	$1.46	$10.2K	7,000
Oct 3, 2022	Chau Hoi Shuen Solina Holly	10% Owner	Buy	960,000	$1.25	$1.20M1.2% OS	7,885,641
Oct 3, 2022	Fried Robert N	Cheif Executive Officer	Buy	80,000	$1.25	$100.0K	972,314
Jun 21, 2022	Chau Hoi Shuen Solina Holly	10% Owner	Buy	60,037	$1.66	$99.9K	6,925,641
Mar 16, 2022	Fried Robert N	CEO	Buy	25,000	$2.16	$54.0K	88,001+40%
May 17, 2021	Fried Robert N	CEO	Buy	10,000	$6.65	$66.5K	63,001

NAGE Insider Selling Activity

The following table shows recent insider sales of Niagen Bioscience Inc (NAGE) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Dec 13, 2024	Jaksch Frank L Jr	Director	Sell	37,161	$6.19	$230.0K	244,179
Aug 26, 2024	Patrick Kristin	Director	Sell	23,000	$3.57	$82.1K	0Exit
Mar 17, 2021	BLOCK STEPHEN A		Sell	52,500	$11.92	$625.8K	16,667-76%